Table 2.
Demographic and clinical data of the cases deceased due to thromboembolism
| variable | N (%) | ||
|---|---|---|---|
| Type of hospital | Educational | 21 (77.8) | |
| Private | 5 (18.5) | ||
| Charity | 1 (3.7) | ||
| BMIa | < 30 | 23 (85.2) | |
| 30–40 | 4 (14.8) | ||
| ≥ 40 | 0 | ||
| Blood Group | A+ | 11 (40.7) | |
| O+ | 8 (29.6) | ||
| B+ | 5 (18.5) | ||
| AB+ | 2 (7.4) | ||
| O− | 1 (3.7) | ||
| A− | 0 | ||
| B− | 0 | ||
| AB− | 0 | ||
| Delivery Type | NVDb | 6 (22.2) | |
| CSc | Emergency | 7 (25.9) | |
| Elective | 14 (51.9) | ||
| Parity | ≥3 | 10 (37) | |
| < 3 | 17 (63) | ||
| Infant gender | Male | 14 (51.9) | |
| Female | 13 (48.1) | ||
| 1st min. Apgar Score | 0 | 6 (22.2) | |
| 5 | 1 (3.7) | ||
| 6 | 1 (3.7) | ||
| 7 | 4 (14.8) | ||
| 8 | 3 (11.1) | ||
| 9 | 12 (44.4) | ||
| Death time | Morning shift | 18 (66.7) | |
| Evening shift | 9 (33.3) | ||
| Delivery to death (days) | 1 | 20 (74.1) | |
| 2 | 3 (11.1) | ||
| 3 | 1 (3.7) | ||
| 4 | 1 (3.7) | ||
| 7 | 1 (3.7) | ||
| 12 | 1 (3.7) | ||
| Blood transfusion | Yes | 11 (40.7) | |
| No | 16 (59.3) | ||
| Heparin prescription | Yes | Single dose | 6 (22.2) |
| multiple doses | 5 (18.5) | ||
| No | 16 (59.3) | ||
| Time of Heparin prescription | Before surgery | 5 (18.5) | |
| After surgery | 1 (3.7) | ||
| Before & after surgery | 5 (18.5) | ||
| None | 16 (59.3) | ||
| Preterm labor | Yes | 13 (48.1) | |
| No | 14 (51.9) | ||
| IUFDd | Yes | 7 (25.9) | |
| No | 20 (74.1) | ||
| Postpartum hemorrhage | Yes | 7 (25.9) | |
| No | 20 (74.1) | ||
| Prolonged labor | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Instrumental delivery | Yes | 2 (7.4) | |
| No | 25 (92.6) | ||
| Sepsis | Yes | 3 (11.1) | |
| No | 24 (88.9) | ||
| Multiple pregnancy | Yes | 3 (11.1) | |
| No | 24 (88.9) | ||
| IVF/ARTe | Yes | 4 (14.8) | |
| No | 23 (85.2) | ||
| Antiphospholipid syndrome | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Cardiac Disease | Yes | 8 (29.6) | |
| No | 19 (70.4) | ||
| Hypothyroidism | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Cancer | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Diabetes | Yes | 4 (14.8) | |
| No | 23 (85.2) | ||
| Rheumatoid disease | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Hereditary thrombophilia | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Preeclampsia | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
| Chronic hypertension | Yes | 3 (11.1) | |
| No | 24 (88.9) | ||
| Thromboembolism history | Yes | 1 (3.7) | |
| No | 26 (96.3) | ||
abody mass index, bnormal vaginal delivery, ccesarean section, dintra uterine fetal demise, ein vitro fertilization/ assisted reproductive technology